The choice of analgesia after cancer surgery may play a role in the onset of cancer recurrence. Particularly opioids seem to promote cancer cell proliferation and migration. Based on this consideration, we assessed the impact of perioperative analgesia choice on cancer recurrence after curative surgery for stage I non-small cell lung cancer (NSCLC).

Impact of analgesia on cancer recurrence and mortality within 5 years after stage I non-small cell lung cancer resection

Rosboch, Giulio Luca;Ceraolo, Edoardo;De Domenici, Ilaria;Guerrera, Francesco;Balzani, Eleonora;Lyberis, Paraskevas;Ruffini, Enrico;Brazzi, Luca
2022-01-01

Abstract

The choice of analgesia after cancer surgery may play a role in the onset of cancer recurrence. Particularly opioids seem to promote cancer cell proliferation and migration. Based on this consideration, we assessed the impact of perioperative analgesia choice on cancer recurrence after curative surgery for stage I non-small cell lung cancer (NSCLC).
2022
108
4
364
370
Analgesia; NSCLC; cancer; opioids; peridural; recurrence; thoracic surgery
Rosboch, Giulio Luca; Ceraolo, Edoardo; De Domenici, Ilaria; Guerrera, Francesco; Balzani, Eleonora; Lyberis, Paraskevas; Ruffini, Enrico; Brazzi, Luca
File in questo prodotto:
File Dimensione Formato  
160 - 2022 Impact of analgesia - Rosboch.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 357.34 kB
Formato Adobe PDF
357.34 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1870660
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact